申请人:Hoffman-La Roche Inc.
公开号:US07691863B2
公开(公告)日:2010-04-06
The present invention relates to compounds of the formula
wherein R1 to R4 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB2 receptors.
本发明涉及以下式子的化合物:其中R1至R4如描述和权利要求所定义的,以及其药学上可接受的盐。这些化合物可用于治疗和/或预防与CB2受体调节相关的疾病。